[1] |
CHE Jinjing, LI Na.
General considerations on bioanalytical methods for comparative evaluation of biosimilars immunogenicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 721-728.
|
[2] |
JIN Le, JIANG Duochen, CHEN Hongxiao, LIU Su, CHEN Zhaolin, JU Jing.
Quercetin reverses adriamycin resistance by activating GSK-3β/β-catenin pathways through GAS5 in breast cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1344-1351.
|
[3] |
PAN Zhanhe, WANG Xin, SU An, ZHANG Peng, JI Haonan, WANG Xiaomei.
Mechanism of celecoxib reverses adriamycin resistance in NK/T cell lymphoma cells by Notch 1/NF-κB/STAT3 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1330-1336.
|
[4] |
CHEN Wang, WEN Chun-jie, FU Li-juan.
Preliminary study of the CYP2C19 genotype in the application of Chinese herbal medicine metabolism screening
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1016-1020.
|
[5] |
SHEN Qun-shan, HUANG Hou-bao, PAN Cai-ming, XUE Jun, CAI Zhang-yu, WANG Xiao, JIANG Shu-chuan.
Prevention effect of 4-HPR on bladder tumor in SD rats: An in vivo experiment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 972-977.
|
[6] |
YANG Yan-lang1,2, ZOU He-qun1, ZHANG Dao-you2, WANG Yu-wei2, LI Fan-xia2, GAO Chao-qing2, XU Hai-hong2, CHENG Xiao-mei2.
Renal tubular protection effect of combining benazepril and spironolactone in adriamycin-induced nephritic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 381-386.
|
[7] |
ZHAO Wen-ying, CHEN Dong-yun, XING Wen, WU Ming , YANG Zhi-min, JI Zhao-ning.
Primary exploration on the protective effect of phosphocreatine sodium on adriamycin-induced cardiotoxicity in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 259-262.
|
[8] |
CHEN Ji-hong, ZHOU Dong, GAO Kun, HE Wei-ming,WANG Yue-juan, SUN Wei.
Expression of NF-κB and IκB in rats with adriamycin nephropathy and the role of Dahuangzhechong Wan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(1): 22-26.
|
[9] |
SU Jing-hua, SUN Jian-guo, WANG Guang-ji.
Current practices and recommendations of in vitro induction of Cytochrome P450
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(8): 954-960.
|
[10] |
LIU Yi-ming, LIN Ai-hua, DENG Shi-gui, WU Zhi-feng, OU Run-mei.
Tissue distribution of adriamycin-loaded chitosan nanoparticles surface-modified with glycyrrhizin in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(1): 66-71.
|
[11] |
YANG Yan-lang, ZHANG Dao-you, WANG Xiang-ming, CUI Ming-chun, WU Xiao-dong.
Renoprotective effect and mechanisms of benazepril and pentifylline on adriamycin nephropathy rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 736-740.
|
[12] |
ZHOU guo-yong, HU Sen, LV Yi, SONG Qi.
Effects of carbachol on inflammatory cytokines expression of rat abdominal macrophages stimulated by lipopolysaccharide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(12): 1361-1365.
|
[13] |
YAO Rong-xin, FENG Liang-hua, XIA Yi-zi, ZHU Bao-ling.
Study on protection and mechanism for adriamycin-induced cardiotoxicity with tiopronin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1216-1220.
|
[14] |
YANG Jing-ya, WANG Xiao-ji, ZHANG Jian.
Antitumor effect of combination of carboxymethyl-chitosan and Adriamycin in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1253-1257.
|
[15] |
CHEN Rong-sheng, LUO Dong-jiao, CHEN Li, TONG Xia-sheng, CHEN Hao, WANG En-zhi.
Concentrations of tumor necrosis factor receptors at prostatic secretion in male patients with chronic pelvic pain syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1304-1307.
|